T7-functionalized cationic peptide as a nanovehicle for co-delivering paclitaxel and siR-MeCP2 to target androgen-dependent and androgen independent prostate cancer
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.